Skip to main content

01.12.2017 | Review | Ausgabe 1/2017 Open Access

World Journal of Surgical Oncology 1/2017

Laparoscopic intersphincteric resection versus an open approach for low rectal cancer: a meta-analysis

World Journal of Surgical Oncology > Ausgabe 1/2017
Hanyu Chen, Bin Ma, Peng Gao, Hongchi Wang, Yongxi Song, Linhao Tong, Peiwen Li, Zhenning Wang



The aim of this study was to compare the short-term and mid-term effects of laparoscopic intersphincteric resection with the conventional open approach for patients with low rectal cancer through a meta-analysis.


The PubMed, EMBASE, Cochrane, and Ovid databases were searched for eligible studies until March 2017. Operation time, blood loss, circumferential resection margin-positive rate, distal margin length, number of resected lymph nodes, diverting stoma rate, postoperative overall morbidity, anastomotic leakage, and hospital stay were the main short-term effect endpoints. We also examined disease-free survival, overall survival, local recurrence, and post-operational anal function as secondary outcomes to evaluate the mid-term effects of laparoscopic surgery.


Five studies involving 620 patients were included in the analyses. Compared with the open approach, the laparoscopic ISR had less blood loss (weighted mean difference [WMD] = − 214.65 ml, 95% CI [− 370.44, − 196.13], p < 0.01), less postoperative overall morbidity (OR = 0.58, 95% CI [0.40, 0.86], p < 0.01), and shorter duration of hospital stay (WMD = − 5.87 days, 95% CI [− 11.35, − 0.40], p < 0.05); however, the operation time was significantly longer in the laparoscopic group (WMD = 47.34 min, 95% CI [4.10, 90.58], p < 0.05). No other significant differences were observed.


Laparoscopic ISR for low rectal cancer offers fewer complications and faster recovery, with similar operation quality and mid-term oncological results than the conventional approach. Although this technique is comparatively more complex than the conventional approach and requires practice, laparoscopic ISR shows great potential as a surgical option and deserves further clinical study.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

World Journal of Surgical Oncology 1/2017 Zur Ausgabe

Neu im Fachgebiet Chirurgie

28.04.2021 | Wechselwirkungen der Krebstherapie | Interview | Ausgabe 5/2021

Sicher therapieren trotz komplexer Medikation

Interview mit Prof. Dr. Ulrich Jaehde, Leiter der Abteilung Klinische Pharmazie am Pharmazeutischen Institut der Rheinischen Friedrich-Wilhelms-Universität Bonn

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.